MedTrace Logo

Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome

NCT02538692 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2017-04-18

No results posted yet for this study

Summary

The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).

Conditions

  • Diarrhea-predominant Irritable Bowel Syndrome

Interventions

DRUG

Tong-Xie-Yao-Fang

Tong-Xie-Yao-Fang is a traditional Chinese formula. It is used for diarrhea management.

DRUG

Placebo

The placebo is the same as Tong-Xie-Yao-Fang in appearance.

Sponsors & Collaborators

  • Chengdu University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-01-31
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538692 on ClinicalTrials.gov